Comment on: Clinical benefits of ezetimibe: absence of proof is just that

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.18, 2013-12, pp. : 2611-2613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical benefits of ezetimibe use: is absence of proof, proof of absence?

By Gouni-Berthold Ioanna Mikhailidis Dimitri P. Rizzo Manfredi

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 1985-1988

Informa Healthcare

Access to resources Recommend Favorite

Ezetimibe/simvastatin provides VYTAL benefits in diabetic patients

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Ezetimibe

By Darkes M.J.M. Poole R.M. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 67-76

Adis International

Access to resources Recommend Favorite

Ezetimibe

By Bays Harold

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1587-1604

Informa Healthcare

Access to resources Recommend Favorite

Ezetimibe/Simvastatin: A Guide to its Clinical Use in Hypercholesterolemia

By Lyseng-Williamson Katherine A.

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 49-56

Adis International

Access to resources Recommend Favorite